next generation probiotics

EnteroBiotix Initiates Phase 2 study of microbiome drug EBX-102 in liver cirrhosis and hepatic encephalopathy

Hepatic encephalopathy is a debilitating and recurring condition that causes neuropsychiatric conditions and is a common complication of cirrhosis.

Sequential and Johnson & Johnson enter partnership to develop new genomic-based skin test

Oliver Worsley: ‘The collaboration will give us the opportunity to further understand how molecular changes on the skin may translate to skin and human health’.

TargEDys: the potential of LpWJL as a potent probiotic supporting juvenile growth

New study shows that these probiotic properties are strain-specific and involve NOD2 signaling. Components of its cell wall could be novel postbiotics.

Sacco System launches Microbiome, the complete suite to support companies worldwide

Marco Caspani: ‘With the launch of our new Microbial Therapeutic business-line we are directing our efforts and strong focus to the field of Biotherapeutics’.

Holobiome and Johnson & Johnson enter partnership to develop next-generation probiotics for infant and maternal health

Microbiome platform company Holobiome announces collaboration to support infant and maternal immune health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.